Kelly Raquel Voigt

Kelly Raquel Voigt

Auto-generated profile, based on publicly available information

Kelly Raquel Voigt

Department of Surgical Oncology and Gastrointestinal Surgery Erasmus MC Cancer Institute Rotterdam The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2023 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
KVKelly R Voigt
Kelly R Voigt
LWLissa Wullaert
Lissa Wullaert
MGMichelle R de Graaff
Michelle R de Graaff
CVCornelis Verhoef
Cornelis Verhoef
DGDirk Jan Grünhagen
Dirk Jan Grünhagen
Textbook outcome is a multidimensional quality measurement, which comprises the desirable short-term outcomes after surgery. This composite measure is reached when a patient meets all predefined requirements, resulting in a broader reflection of quality of care than single outcome measures. This aids clinicians in daily practice, giving insight into the quality of the entire surgical pathway from surgery to postoperative outcomes. Textbook outcome also provides an opportunity to evaluate variation between hospitals in a more objective manner, as it provides higher event rates and more power to detect differences than single outcomes.

1 July 2024 in Colorectal Disease
Verified
Journal Article
Open access
KVKelly R. Voigt
Kelly R. Voigt
LWLissa Wullaert
Lissa Wullaert
PGP. D. Gobardhan
P. D. Gobardhan
PDP. G. Doornebosch
P. G. Doornebosch
CVCornelis Verhoef
Cornelis Verhoef
DGDirk J. Grünhagen
Dirk J. Grünhagen
Aim: Follow‐up for colorectal cancer (CRC) necessitates regular monitoring of carcinoembryonic antigen (CEA) at the hospital. Capillary home‐based blood collection, including minimally invasive techniques such as lancet sampling or an automated upper arm device (TAP‐II), has the potential to replace a significant portion of hospital‐based blood sampling, thereby enhancing self‐reliance and quality of life. The objectives of this study were to assess the feasibility, reliability and preference for CEA blood collection.Methods: Baseline venous and capillary (by lancet and TAP‐II) blood samples were collected from 102 participants, including 20 CRC patients with elevated CEA levels, 60 CRC patients undergoing postoperative outpatient monitoring and 20 healthy volunteers. The second group performed capillary blood collections at home on two consecutive follow‐up appointments and subsequently sent them to the hospital. Satisfaction was assessed via patient reported outcome measures on pain, burden, ease of use and preference.Results: The Pearson's correlation test of all usable samples resulted in a linear coefficient of 0.998 (95% CI 0.997–0.998) for the TAP‐II method and 0.997 (95% CI 0.996–0.998) for the lancet method, both compared to venipuncture. Following the initial blood collection, 86% of the participants (n = 102) favoured the TAP‐II, rating it as the least painful and burdensome option. After two home‐based blood samples, the preference for the TAP‐II method persisted, with 64% of the patients endorsing its use.Conclusion: This study demonstrated the feasibility of home‐based capillary sampling of CEA. The TAP‐II blood collection is the most reliable method and is preferred by patients over venipuncture and lancet sampling.

12 October 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
KVKelly Raquel Voigt
Kelly Raquel Voigt
LWLissa Wullaert
Lissa Wullaert
DHDiederik J Höppener
Diederik J Höppener
JSJennifer M J Schreinemakers
Jennifer M J Schreinemakers
PDPascal G Doornebosch
Pascal G Doornebosch
DGDirk Jan Grünhagen
Dirk Jan Grünhagen
Introduction Colorectal cancer (CRC) is the third most common type of cancer in the Netherlands. Approximately 90% of patients can be treated with surgery, which is considered potentially curative. Postoperative surveillance during the first 5 years after surgery pursues to detect metastases in an early, asymptomatic and treatable stage. Multiple large randomised controlled trials have failed to show any (cancer-specific) survival benefit of intensive postoperative surveillance compared with a minimalistic approach in patients with CRC. This raises the question whether an (intensive) in-hospital postoperative surveillance strategy is still warranted from both a patient well-being and societal perspective. A more modern, home-based surveillance strategy could be beneficial in terms of patients’ quality of life and healthcare costs. Methods and analysis The multicentre, prospective FUTURE-primary study implements a patient-led home-based surveillance after curative CRC treatment. Here, patients are involved in the choice regarding three fundamental aspects of their postoperative surveillance. First regarding frequency, patients can opt for additional follow-up moments to the minimal requirement as outlined by the current Dutch national guidelines. Second regarding the setting, both in-hospital or predominantly home-based options are available. And third, concerning patient–doctor communication choices ranging from in-person to video chat, and even silent check-ups. The aim of the FUTURE-primary study is to evaluate if such a patient-led home-based follow-up approach is successful in terms of quality of life, satisfaction and anxiety compared with historic data. A successful implementation of the patient-led aspect will be assessed by the degree in which the additional, optional follow-up moments are actually utilised. Secondary objectives are to evaluate quality of life, anxiety, fear of cancer recurrence and cost-effectiveness. Ethics and dissemination Ethical approval was given by the Medical Ethics Review Committee of Erasmus Medical Centre, The Netherlands (2021-0499). Results will be presented in peer-reviewed journals. Trial registration number NCT05656326.

21 March 2023 in Colorectal Disease
Verified
Journal Article
Open access
KVKelly R. Voigt
Kelly R. Voigt
LWLissa Wullaert
Lissa Wullaert
CVCornelis Verhoef
Cornelis Verhoef
DGDirk J. Grünhagen
Dirk J. Grünhagen
CRChristian Ramakers
Christian Ramakers
Aim: Follow‐up after colorectal cancer requires frequent surveillance of the tumour marker carcinoembryonic antigen (CEA). Home‐based blood sampling could be beneficial in terms of patients' well‐being and societal cost‐effectiveness. Blood sampling by venepuncture is unsuitable for home‐based sampling. The aim of this feasibility study is to evaluate the long‐term whole‐blood stability of CEA.Method: In this prospective feasibility study capillary blood withdrawal was collected in a Hem‐Col® microtube containing a patented stabilization buffer using an internal lithium standard to correct for dilution. Long‐term whole‐blood stability was considered adequate if the relative bias in CEA concentration between delayed analysis of capillary samples and directly processed venepuncture is within the total error margin of CEA.Results: Twenty two colorectal cancer patients were included to determine the stability of CEA in capillary sampling compared with directly processed (i.e. within 2 h) venepuncture sampling. The median time between venous sampling and CEA analysis and capillary sampling and CEA analysis was 2 h (interquartile range 1–4 h) and 76 h (interquartile range 74–95 h), respectively. A Bland–Altman difference plot excluding outliers showed an overall relative bias of −1.23%. The two capillary samples in our outlier analysis also showed the highest lithium concentrations.Conclusion: Home‐based capillary sampling with the use of the Hem‐Col® buffer is a feasible method for CEA determination when analysed within 4 days after blood withdrawal, allowing monitoring for colorectal cancer patients from home. High lithium concentrations due to insufficient filling of the Hem‐Col® tube suggest less reliable CEA measurements.

21 January 2024 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
KVKelly R. Voigt
Kelly R. Voigt
MGMichelle R. de Graaff
Michelle R. de Graaff
CVCornelis Verhoef
Cornelis Verhoef
GKGeert Kazemier
Geert Kazemier
RSRutger J. Swijneburg
Rutger J. Swijneburg
SOS.J. Oosterling
S.J. Oosterling
Textbook outcome (TO) represents a multidimensional quality measurement, encompassing the desirable short-term outcomes following surgery. This study aimed to investigate whether achieving TO after resection of colorectal liver metastases (CRLM) surgery is related to better overall survival (OS) in a national cohort. Data was retrieved from the Dutch Hepato Biliary Audit. A modified definition of TO (mTO) was used because readmissions were only recorded from 2019. mTO was achieved when no severe postoperative complications, mortality, prolonged length of hospital stay, occurred and when adequate surgical resection margins were obtained. To compare outcomes of patients with and without mTO and reduce baseline differences between both groups propensity score matching (PSM) was used for patients operated on between 2014 and 2018. Out of 6525 eligible patients, 81 % achieved mTO. For the cohort between 2014 and 2018, those achieving mTO had a 5-year OS of 46.7 % (CI 44.8-48.6) while non-mTO patients had a 5-year OS of 33.7 % (CI 29.8-38.2), p < 0.001. Not achieving mTO was associated with a worse OS (aHR 1.34 (95 % CI 1.17-1.53), p < 0.001. Median follow-up was 76 months., PSM assigned 519 patients to each group. In the PSM cohort patients achieving mTO, 5-year OS was 43.6 % (95 % CI 39.2-48.5) compared to 36.4 % (95 % CI 31.9-41.2) in patients who did not achieve mTO, p = 0.006. Achieving mTO is associated with improved long-term survival. This emphasizes the importance of optimising perioperative care and reducing postoperative complications in surgical treatment of CRLM.

27 January 2025 in JMIR Cancer
Verified
Journal Article
Open access
KVKelly Voigt
Kelly Voigt
YSYingtao Sun
Yingtao Sun
APAyush Patandin
Ayush Patandin
JHJohanna Hendriks
Johanna Hendriks
RGRichard Hendrik Goossens
Richard Hendrik Goossens
JJJiwon Jung
Jiwon Jung
Background: The rising number of cancer survivors and the shortage of health care professionals challenge the accessibility of cancer care. Health technologies are necessary for sustaining optimal patient journeys. To understand individuals’ daily lives during their patient journey, qualitative studies are crucial. However, not all patients wish to share their stories with researchers. Objective: This study aims to identify and assess patient experiences on a large scale using a novel machine learning–supported approach, leveraging data from patient forums. Methods: Forum posts of patients with colorectal cancer (CRC) from the Cancer Survivors Network USA were used as the data source. Topic modeling, as a part of machine learning, was used to recognize the topic patterns in the posts. Researchers read the most relevant 50 posts on each topic, dividing them into “home” or “hospital” contexts. A patient community journey map, derived from patients stories, was developed to visually illustrate our findings. CRC medical doctors and a quality-of-life expert evaluated the identified topics of patient experience and the map. Results: Based on 212,107 posts, 37 topics and 10 upper clusters were produced. Dominant clusters included “Daily activities while living with CRC” (38,782, 18.3%) and “Understanding treatment including alternatives and adjuvant therapy” (31,577, 14.9%). Topics related to the home context had more emotional content compared with the hospital context. The patient community journey map was constructed based on these findings. Conclusions: Our study highlighted the diverse concerns and experiences of patients with CRC. The more emotional content in home context discussions underscores the personal impact of CRC beyond clinical settings. Based on our study, we found that a machine learning-supported approach is a promising solution to analyze patients’ experiences. The innovative application of patient community journey mapping provides a unique perspective into the challenges in patients’ daily lives, which is essential for delivering appropriate support at the right moment.